fenclonine has been researched along with Myelopathy in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, HS | 1 |
| Olsson, Y | 1 |
| Chase, TN | 1 |
1 review available for fenclonine and Myelopathy
| Article | Year |
|---|---|
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extr | 1974 |
1 other study available for fenclonine and Myelopathy
| Article | Year |
|---|---|
Edema formation and cellular alterations following spinal cord injury in the rat and their modification with p-chlorophenylalanine.
Topics: Animals; Edema; Fenclonine; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Serotonin; Spina | 1990 |